In this narrative review, we focus on the application of tau-PET for identification of pathology in patients with Alzheimer’s dementia (AD), with the particular objective of summarizing the fitness and sensitivity of available tau tracers for the detection of AD pathology. Here, MAPT is linked to Alzheimer disease.